4//SEC Filing
Lovell Stephanie 4
Accession 0000899243-22-036935
CIK 0001756262other
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 4:30 PM ET
Size
18.8 KB
Accession
0000899243-22-036935
Insider Transaction Report
Form 4
Lovell Stephanie
Director
Transactions
- Sale
Common Stock
2022-11-23$59.50/sh−5,657$336,592→ 0 total - Exercise/Conversion
Common Stock
2022-11-22$26.26/sh+1,100$28,886→ 1,100 total - Sale
Common Stock
2022-11-22$58.04/sh−1,100$63,844→ 0 total - Exercise/Conversion
Common Stock
2022-11-23$47.82/sh+5,657$270,518→ 5,657 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-23−5,657→ 8,543 totalExercise: $47.82Exp: 2031-03-22→ Common Stock (5,657 underlying) - Sale
Common Stock
2022-11-22$57.97/sh−3,800$220,286→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-22−3,800→ 14,200 totalExercise: $47.82Exp: 2031-03-22→ Common Stock (3,800 underlying) - Exercise/Conversion
Common Stock
2022-11-22$47.82/sh+3,800$181,716→ 3,800 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-22−1,100→ 1,150 totalExercise: $26.26Exp: 2031-05-27→ Common Stock (1,100 underlying)
Footnotes (1)
- [F1]The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001772054
Filing Metadata
- Form type
- 4
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 4:30 PM ET
- Size
- 18.8 KB